Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR5 | P51681 | 16/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5774157 | 0.86 | CCR5 (0.46) | CCR5CYP2D6KCNH2SLC6A2SLC6A4 | |
| SCHEMBL5234422 | 0.80 | CCR5 (0.53) | CCR5CYP2D6KCNH2 | |
| SCHEMBL5237103 | 0.79 | CCR5 (0.53) | CCR5CYP2D6KCNH2 | |
| SCHEMBL5238420 | 0.78 | CCR5 (0.51) | CCR5CYP2D6KCNH2 | |
| SCHEMBL5234414 | 0.78 | CCR5 (0.57) | CCR5CYP2D6KCNH2 | |
| SCHEMBL5795818 | 0.77 | CCR5 (0.40) | CCR5CYP2D6KCNH2SLC6A2SLC6A4 | |
| SCHEMBL3303563 | 0.75 | CCR5 (0.59) | CCR5CYP2D6KCNH2 | |
| SCHEMBL5238997 | 0.74 | CCR5 (0.58) | CCR5CYP2D6KCNH2 | |
| SCHEMBL5234516 | 0.73 | CCR5 (0.51) | CCR5CYP2D6KCNH2 | |
| SCHEMBL5219971 | 0.72 | CCR5 (0.60) | CCR5CYP2D6KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1648871-A1 | PIPERIDINE OR 8-AZA-BICYCLO 3.2.1 OCT-3-YL DERIVATIVES USEFUL AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | AstraZeneca AB (SE) | 2006-04-26 | — | — | EP | disclosed |
| WO-2005007629-A1 | PIPERIDINE OR 8-AZA-BICYCLO[3.2.1]OCT-3-YL DERIVATIVES USEFUL AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | ASTRAZENECA AB (SE) | 2005-01-27 | — | — | WO | disclosed |